Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Jillian Wilhelmina Paulina Bracht"'
Autor:
Niki Karachaliou, Andres Felipe Cardona, Jillian Wilhelmina Paulina Bracht, Erika Aldeguer, Ana Drozdowskyj, Manuel Fernandez-Bruno, Imane Chaib, Jordi Berenguer, Mariacarmela Santarpia, Masaoki Ito, Jordi Codony-Servat, Rafael Rosell
Publikováno v:
EBioMedicine, Vol 39, Iss , Pp 207-214 (2019)
Background: The activation of multiple signaling pathways jeopardizes the clinical efficacy of EGFR tyrosine kinase inhibitors (TKIs) in EGFR-mutation positive non-small cell lung cancer (NSCLC). Integrin-linked kinase (ILK) regulates the interaction
Externí odkaz:
https://doaj.org/article/eae80d70110840b7b0bf3192ea680da0
Autor:
Niki Karachaliou, Imane Chaib, Andres Felipe Cardona, Jordi Berenguer, Jillian Wilhelmina Paulina Bracht, Jie Yang, Xueting Cai, Zhigang Wang, Chunping Hu, Ana Drozdowskyj, Carles Codony Servat, Jordi Codony Servat, Masaoki Ito, Ilaria Attili, Erika Aldeguer, Ana Gimenez Capitan, July Rodriguez, Leonardo Rojas, Santiago Viteri, Miguel Angel Molina-Vila, Sai-Hong Ignatius Ou, Morihito Okada, Tony S. Mok, Trever G. Bivona, Mayumi Ono, Jean Cui, Santiago Ramón y Cajal, Peng Cao, Rafael Rosell
Publikováno v:
EBioMedicine, Vol 29, Iss , Pp 112-127 (2018)
Epidermal growth factor receptor (EGFR)-mutation-positive non-smallcell lung cancer (NSCLC) is incurable, despite high rates of response to EGFR tyrosine kinase inhibitors (TKIs). We investigated receptor tyrosine kinases (RTKs), Src family kinases a
Externí odkaz:
https://doaj.org/article/d4a85629cde14b10a642cf79a55d7f2c
Autor:
Mariacarmela Santarpia, Andrés Aguilar, Imane Chaib, Andrés Felipe Cardona, Sara Fancelli, Fernando Laguia, Jillian Wilhelmina Paulina Bracht, Peng Cao, Miguel Angel Molina-Vila, Niki Karachaliou, Rafael Rosell
Publikováno v:
Cancers, Vol 12, Iss 6, p 1475 (2020)
Treatment of advanced (metastatic) non-small-cell lung cancer (NSCLC) is currently mainly based on immunotherapy with antibodies against PD-1 or PD-L1, alone, or in combination with chemotherapy. In locally advanced NSCLC and in early resected stages
Externí odkaz:
https://doaj.org/article/ee7be6f1914f49c0805333ca436bea94
Autor:
Jillian Wilhelmina Paulina Bracht, Niki Karachaliou, Trever Bivona, Richard B. Lanman, Iris Faull, Rebecca J. Nagy, Ana Drozdowskyj, Jordi Berenguer, Manuel Fernandez-Bruno, Miguel Angel Molina-Vila, Rafael Rosell
Publikováno v:
Cancers, Vol 11, Iss 9, p 1381 (2019)
BRAF V600 mutations have been found in 1−2% of non-small-cell lung cancer (NSCLC) patients, with Food and Drug Administration (FDA) approved treatment of dabrafenib plus trametinib and progression free survival (PFS) of 10.9 months. However, 50−8
Externí odkaz:
https://doaj.org/article/a6fcd5443b7e40bdbed93580c4eb6492
Autor:
Jillian Wilhelmina Paulina Bracht, Valentina Guarneri, Ana Giménez-Capitán, Carles Codony-Servat, Filippo de Marinis, Giulia Pasello, Miguel Angel Molina-Vila, Rafael Rosell, Pierfranco Conte, Antonio Passaro, Imane Chaib, Matteo Fassan, Alessandro Dal Maso, Jordi Codony-Servat, Erika Aldeguer, Niki Karachaliou, Laura Bonanno, Jordi Berenguer, Ilaria Attili
Publikováno v:
Translational Lung Cancer Research
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Transl Lung Cancer Res
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Transl Lung Cancer Res
Background: The role of MET alterations in non-small cell lung cancer (NSCLC) is increasing and several targeted agents are under evaluation. MET exon 14 skipping mutations and MET amplifications are associated with potential sensitivity to MET inhib
Publikováno v:
OncoTargets and Therapy. 12:4567-4575
Discovered in 2007, anaplastic lymphoma kinase (ALK) gene rearrangements positive (ALK+) lung cancers compose a small subset of non-small cell lung cancer (NSCLC), with rapidly expanded treatments. There are currently several ALK inhibitors, includin
Autor:
Andrés F. Cardona, Carles Codony-Servat, Jordi Berenguer, Ana Giménez-Capitán, Jordi Codony-Servat, Masaoki Ito, Rafael Rosell, Jillian Wilhelmina Paulina Bracht, Niki Karachaliou, Ana Drozdowskyj
Publikováno v:
Clinical Lung Cancer. 20:167-177
Introduction Epidermal growth factor receptor (EGFR) pathway deregulation promotes the acquisition of stemlike properties in non–small-cell lung cancer. EGFR inhibition through NOTCH enriches lung cancer stem cells (CSCs). Src through Yes-associate
Autor:
Nicolas Potie, Jillian Wilhelmina Paulina Bracht, Sarah Warren, Chung-Ying Huang, Miguel Angel Molina-Vila, Carlos Pedraz-Valdunciel, Ana Giménez-Capitán, Rafael Rosell
Publikováno v:
Scientific Reports
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Extracellular vesicles (EVs) are double-layered phospholipid membrane vesicles that are released by most cells and can mediate intercellular communication through their RNA cargo. In this study, we tested if the NanoString nCounter platform can be us
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf48a5d8af35475cabd4e60377ced18a
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2485
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2485
Autor:
Andrés Aguilar, Eric J Johnson, Chung-Ying Huang, Joseph M. Beechem, Noemi Reguart, Mónica Garzón, Beatriz Garcia, Sarah Warren, Jillian Wilhelmina Paulina Bracht, Clara Mayo-de-las-Casas, Alejandro Martinez-Bueno, Ivana-Gabriela Sullivan, Ana Giménez-Capitán, Núria Jordana-Ariza, Jay Gerlach, Cristina Teixidó, Rafael Rosell, Santiago Viteri-Ramirez, Juan José García, Miguel Angel Molina-Vila
Publikováno v:
CLINICAL CHEMISTRY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Clinical Chemistry
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Clinical Chemistry
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Background With the advent of precision oncology, liquid biopsies are quickly gaining acceptance in the clinical setting. However, in some cases, the amount of DNA isolated is insufficient for Next-Generation Sequencing (NGS) analysis. The nCounter p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d4b324a464cdc6716f91f4f2dd19d6b
https://ddd.uab.cat/record/272084
https://ddd.uab.cat/record/272084
Autor:
Jillian Wilhelmina Paulina Bracht, Clara Mayo-de-las-Casas, Jordi Berenguer, Niki Karachaliou, Rafael Rosell
Publikováno v:
Current Oncology Reports. 22